Volitionrx VNRX
NYSE VNRX
$0.44 -0.04 (-8.33%)
At close: Aug 20, 2026 · 4:00 PM EDT

Volitionrx (VNRX) Total Non-Current Liabilities (2018 - 2026)

Volitionrx's (VNRX) quarterly Total Non-Current Liabilities came in at $31.0 million in Q3 2025, up 514.48% YoY from $5.0 million in Q3 2024, and down 4.87% on a QoQ basis from $32.6 million in Q2 2025.

Volitionrx (VNRX) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends

Volitionrx (VNRX) has 8 years of Total Non-Current Liabilities data on file, last reported at $31.0 million in Q3 2025.

  • Quarterly Total Non-Current Liabilities rose 514.48% year-over-year to $31.0 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $31.0 million (up 514.48% YoY) and the FY2024 annual result came in at $27.7 million, up 474.36% from the prior year.
  • Total Non-Current Liabilities slipped to $31.0 million in Q3 2025, from $32.6 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $32.6 million in Q2 2025 to a low of $3.2 million in Q3 2023.
  • A 5-year average of $13.9 million and a median of $8.7 million in 2021 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2022 — Total Non-Current Liabilities sank 58.45% — and 2025, when it surged 552.55%.
  • Tracing VNRX's Total Non-Current Liabilities over 5 years: stood at $9.7 million in 2021, then slumped by 58.45% to $4.0 million in 2022, then rose by 19.57% to $4.8 million in 2023, then soared by 474.36% to $27.7 million in 2024, then increased by 11.76% to $31.0 million in 2025.
  • The last three Total Non-Current Liabilities figures came in at $31.0 million (Q3 2025), $32.6 million (Q2 2025), and $29.3 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 21.28 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 40.90 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 42.74 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 2.57 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 3.68 Bn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 23.89 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 9.07 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 3.44 Bn
10 Volitionrx 1.19 Mn -1.60 Mn - 28.35 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 28.35 Mn
Dec 31, 2025 30.26 Mn
Sep 30, 2025 30.98 Mn
Jun 30, 2025 32.56 Mn
Mar 31, 2025 29.27 Mn
Dec 31, 2024 27.72 Mn
Sep 30, 2024 5.04 Mn
Jun 30, 2024 4.99 Mn
Mar 31, 2024 4.56 Mn
Dec 31, 2023 4.83 Mn
Sep 30, 2023 3.24 Mn
Dec 31, 2022 4.04 Mn
Mar 31, 2022 20.82 Mn
Dec 31, 2021 9.71 Mn
Sep 30, 2021 8.77 Mn
Jun 30, 2021 8.56 Mn
Dec 31, 2020 9.80 Mn
Sep 30, 2019 2.73 Mn
Dec 31, 2018 3.02 Mn